BACKGROUND: Familial mediterranean fever (FMF) is a recessively inherited disease characterized by recurrent crises of fever, abdominal, articular and/or thoracic pain. The most severe complication is the development of renal amyloidosis. Over 35 mutations have been discovered so far in the gene responsible for the disease, MEFV. This article aims at determining a correlation between the MEFV genotype and the occurrence of amyloidosis in FMF patients, in addition to the study of the modifying effects of the SAA1 (type 1 serum amyloid A protein) and MICA (Major Histocompatibility Complex (MHC) class-I-chain-related gene A) genes on this severe complication. METHODS: Fourteen MEFV mutations were screened and the SAA1 and MICA polymorphisms tested in 30 FMF patients with amyloidosis and 40 FMF patients without amyloidosis. RESULTS: The M694V and V726A allelic frequencies were, respectively, significantly higher and lower in the group with amyloidosis, compared to the control FMF group. The beta and gamma SAA1 alleles were more frequently encountered in the group without amyloidosis, whereas the alpha allele was significantly more observed in FMF patients with amyloidosis (p < 0.025). All the MICA alleles were encountered in both patients' groups, but none of them was significantly associated with amyloidosis. CONCLUSIONS: The results suggest a protective effect of the SAA1 beta and gamma alleles on the development of amyloidosis and show the absence of a MICA modifying effect on amyloidosis development. Testing these polymorphisms on a larger sample will lead to more definite conclusions.
BACKGROUND:Familial mediterranean fever (FMF) is a recessively inherited disease characterized by recurrent crises of fever, abdominal, articular and/or thoracic pain. The most severe complication is the development of renal amyloidosis. Over 35 mutations have been discovered so far in the gene responsible for the disease, MEFV. This article aims at determining a correlation between the MEFV genotype and the occurrence of amyloidosis in FMFpatients, in addition to the study of the modifying effects of the SAA1 (type 1 serum amyloid A protein) and MICA (Major Histocompatibility Complex (MHC) class-I-chain-related gene A) genes on this severe complication. METHODS: Fourteen MEFV mutations were screened and the SAA1 and MICA polymorphisms tested in 30 FMFpatients with amyloidosis and 40 FMFpatients without amyloidosis. RESULTS: The M694V and V726A allelic frequencies were, respectively, significantly higher and lower in the group with amyloidosis, compared to the control FMF group. The beta and gamma SAA1 alleles were more frequently encountered in the group without amyloidosis, whereas the alpha allele was significantly more observed in FMFpatients with amyloidosis (p < 0.025). All the MICA alleles were encountered in both patients' groups, but none of them was significantly associated with amyloidosis. CONCLUSIONS: The results suggest a protective effect of the SAA1 beta and gamma alleles on the development of amyloidosis and show the absence of a MICA modifying effect on amyloidosis development. Testing these polymorphisms on a larger sample will lead to more definite conclusions.
Authors: Y Kawabata; H Ikegami; Y Kawaguchi; T Fujisawa; M Hotta; H Ueda; M Shintani; K Nojima; M Ono; M Nishino; H Taniguchi; S Noso; K Yamada; N Babaya; T Ogihara Journal: Hum Immunol Date: 2000-06 Impact factor: 2.850
Authors: K Konstantopoulos; S Michael; A Kanta; C Pecheux; J Grateau; H Helioti; C Stathakis Journal: Scand J Rheumatol Date: 2000 Impact factor: 3.641
Authors: Y J Lee; F Y Huang; C H Wang; F S Lo; K W Tsan; C H Hsu; C Y Huang; S C Chang; J G Chang Journal: J Pediatr Endocrinol Metab Date: 2000-05 Impact factor: 1.634
Authors: M Moriguchi; C Terai; Y Koseki; M Uesato; A Nakajima; S Inada; M Nishinarita; S Uchida; A Nakajima; S Y Kim; C L Chen; N Kamatani Journal: Hum Genet Date: 1999-10 Impact factor: 4.132
Authors: C Cazeneuve; T Sarkisian; C Pêcheux; M Dervichian; B Nédelec; P Reinert; A Ayvazyan; J C Kouyoumdjian; H Ajrapetyan; M Delpech; M Goossens; C Dodé; G Grateau; S Amselem Journal: Am J Hum Genet Date: 1999-07 Impact factor: 11.025
Authors: A Mimouni; N Magal; N Stoffman; T Shohat; A Minasian; M Krasnov; G J Halpern; J I Rotter; N Fischel-Ghodsian; Y L Danon; M Shohat Journal: Pediatrics Date: 2000-05 Impact factor: 7.124
Authors: C Cazeneuve; H Ajrapetyan; S Papin; F Roudot-Thoraval; D Geneviève; E Mndjoyan; M Papazian; A Sarkisian; A Babloyan; B Boissier; P Duquesnoy; J C Kouyoumdjian; E Girodon-Boulandet; G Grateau; T Sarkisian; S Amselem Journal: Am J Hum Genet Date: 2000-10-03 Impact factor: 11.025